inconclusive

related words
mistake
pivotal
exacting
toxicology
var
enrolling
developmental
scotland
pulmonary
observed
levulan
careful
elesclomol
regarded
migrating
kerastick
asthma
inexpensive
takeda
zileuton
related documents
1411460--2/10/2010--UBIQUITECH_SOFTWARE_CORP
1157601--3/20/2008--SYNTA_PHARMACEUTICALS_CORP
892986--3/6/2007--WARREN_RESOURCES_INC
1310094--8/16/2010--ACCENTIA_BIOPHARMACEUTICALS_INC
1388410--5/17/2010--Endeavor_Power_Corp
1157601--3/11/2010--SYNTA_PHARMACEUTICALS_CORP
919722--3/15/2010--SUPERGEN_INC
1097264--3/3/2009--ALLOS_THERAPEUTICS_INC
1203944--10/28/2009--RAPTOR_PHARMACEUTICALS_CORP.
1157601--3/26/2009--SYNTA_PHARMACEUTICALS_CORP
919722--3/16/2009--SUPERGEN_INC
1097264--3/1/2010--ALLOS_THERAPEUTICS_INC
1097264--2/27/2008--ALLOS_THERAPEUTICS_INC
1068796--3/7/2008--MAXYGEN_INC
919722--3/17/2008--SUPERGEN_INC
1157601--3/28/2007--SYNTA_PHARMACEUTICALS_CORP
1097264--3/14/2007--ALLOS_THERAPEUTICS_INC
1373683--10/6/2010--PHOENIX_ENERGY_RESOURCE_CORP
918112--9/13/2007--NEUROBIOLOGICAL_TECHNOLOGIES_INC_/CA/
919722--3/16/2007--SUPERGEN_INC
related topics
{product, candidate, development}
{financial, litigation, operation}
{system, service, information}
{loss, insurance, financial}
{cost, regulation, environmental}
{property, intellectual, protect}
{capital, credit, financial}
{provision, law, control}
{acquisition, growth, future}
{tax, income, asset}
{debt, indebtedness, cash}
{competitive, industry, competition}
{stock, price, share}
{regulation, government, change}
{investment, property, distribution}
{operation, natural, condition}
{interest, director, officer}
{gas, price, oil}
{loan, real, estate}
{customer, product, revenue}